<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="other" dtd-version="1.0" specific-use="sps-1.6" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">5gdVqBb4pZsVFf3k4DWbZWd</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2017001300368</article-id>
      <article-id pub-id-type="doi">10.5935/abc.20170133</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Viewpoint</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Positions, Guidelines and Standardizations. Vehicles of Assistance to Medical Practice</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Sousa</surname>
            <given-names>Ant&#244;nio Carlos Sobral</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="aff" rid="aff2">2</xref>
          <xref ref-type="corresp" rid="c1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cunha</surname>
            <given-names>Claudio Pereira da</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Magalh&#227;es</surname>
            <given-names>Luc&#233;lia Batista Neves Cunha</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kaiser</surname>
            <given-names>Sergio Emanuel</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Saraiva</surname>
            <given-names>Jos&#233; Francisco Kerr</given-names>
          </name>
          <xref ref-type="aff" rid="aff6">6</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <institution content-type="orgname">Universidade Federal de Sergipe</institution>
        <institution content-type="orgdiv1">Departamento de Medicina e N&#250;cleo de P&#243;s gradua&#231;&#227;o em medicina</institution>
        <addr-line>
          <named-content content-type="city">Aracaju</named-content>
          <named-content content-type="state">SE</named-content>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Departamento de Medicina e N&#250;cleo de P&#243;s gradua&#231;&#227;o em medicina da Universidade Federal de Sergipe, Aracaju, SE; - Brazil</institution>
        <institution content-type="normalized">Universidade Federal de Sergipe</institution>
      </aff>
      <aff id="aff2">
        <label>2</label>
        <institution content-type="orgname">Funda&#231;&#227;o S&#227;o Lucas</institution>
        <institution content-type="orgdiv1">Centro de Ensino e Pesquisa</institution>
        <addr-line>
          <named-content content-type="city">Aracaju</named-content>
          <named-content content-type="state">SE</named-content>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Centro de Ensino e Pesquisa da Funda&#231;&#227;o S&#227;o Lucas, Aracaju, SE; - Brazil</institution>
      </aff>
      <aff id="aff3">
        <label>3</label>
        <institution content-type="orgname">Universidade Federal do Paran&#225;</institution>
        <addr-line>
          <named-content content-type="city">Curitiba</named-content>
          <named-content content-type="state">PR</named-content>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Universidade Federal do Paran&#225;, Curitiba, PR; - Brazil</institution>
        <institution content-type="normalized">Universidade Federal do Paran&#225;</institution>
      </aff>
      <aff id="aff4">
        <label>4</label>
        <institution content-type="orgname">Universidade Federal da Bahia</institution>
        <addr-line>
          <named-content content-type="city">Salvador</named-content>
          <named-content content-type="state">BA</named-content>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Universidade Federal da Bahia, Salvador, BA; - Brazil</institution>
        <institution content-type="normalized">Universidade Federal da Bahia</institution>
      </aff>
      <aff id="aff5">
        <label>5</label>
        <institution content-type="orgname">Universidade do Estado do Rio de Janeiro</institution>
        <addr-line>
          <named-content content-type="city">Rio de Janeiro</named-content>
          <named-content content-type="state">RJ</named-content>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ; - Brazil</institution>
        <institution content-type="normalized">Universidade do Estado do Rio de Janeiro</institution>
      </aff>
      <aff id="aff6">
        <label>6</label>
        <institution content-type="orgname">Pontif&#237;cia Universidade Cat&#243;lica de Campinas</institution>
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">SP</named-content>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original">Pontif&#237;cia Universidade Cat&#243;lica de Campinas (PUC-Camp), S&#227;o Paulo, SP - Brazil</institution>
        <institution content-type="normalized">Pontif&#237;cia Universidade Cat&#243;lica de Campinas</institution>
      </aff>
      <author-notes>
        <corresp id="c1"><bold>Mailing Address: Ant&#244;nio Carlos Sobral Sousa</bold>, Av. Dep. Silvio Teixeira, 490/1201. Postal Code 49025-100, Jardins, Aracaju, SE - Brazil. E-mail: <email>acssousa@terra.com.br</email></corresp>
        <fn fn-type="con">
          <p>
            <bold>Author contributions</bold>
          </p>
          <p>Conception and design of the research, Acquisition of data, Analysis and interpretation of the data and Statistical analysis: Sousa ACS, Cunha CP, Magalh&#227;es LBNC, Kaiser SE, Saraiva JFK; Obtaining financing: Sousa ACS, Cunha CP; Writing of the manuscript and Critical revision of the manuscript for intellectual content: Sousa ACS.</p>
        </fn>
        <fn fn-type="conflict">
          <p>
            <bold>Potential Conflict of Interest</bold>
          </p>
          <p>No potential conflict of interest relevant to this article was reported.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <month>10</month>
        <year>2017</year>
      </pub-date>
      <volume>109</volume>
      <issue>4</issue>
      <fpage>368</fpage>
      <lpage>369</lpage>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>06</month>
          <year>2017</year>
        </date>
        <date date-type="rev-recd">
          <day>19</day>
          <month>06</month>
          <year>2017</year>
        </date>
        <date date-type="accepted">
          <day>19</day>
          <month>06</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/" xml:lang="en">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <kwd-group xml:lang="en">
        <title>Keywords:</title>
        <kwd>Evidence-Based Practice</kwd>
        <kwd>Delivery of Health Care</kwd>
        <kwd>Practice Guidelines as Topic</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>In a field as complex and rapidly changing as cardiology, Clinical Practice Guidelines are important tools for applying evidence-based medicine to patient care. It should be noted, however, that adherence to them varies widely, and that some doctors have concerns that these instruments characterize a rigid or simplified practice of medicine. Therefore, the appropriate implementation of health care guidelines is of great interest to national organizations, professional societies, health care providers, policy makers, legal field of medicine, patients and the public. Given the importance of the theme, several tools have been developed to assess the credibility of existing guidelines,<xref ref-type="bibr" rid="B1">1</xref> and guidances have been elaborated step-by-step for the implementation of a practical and reliable document.<xref ref-type="bibr" rid="B2">2</xref>
		</p>
    <p>Since 1992, the Brazilian Society of Cardiology (SBC) has systematically published guidelines on the most relevant themes of the specialty.<xref ref-type="bibr" rid="B3">3</xref> However, there was a lack of discernment regarding three important concepts<xref ref-type="bibr" rid="B4">4</xref> in the intention of the departments that integrate the SBC to carry out guidelines: a) "Guideline" - a term that should be reserved for the document that formally summarizes the evidences in the areas of diagnosis and therapeutics of pathologies; b) "Communication" (or "Standardization") shall be used for manuscripts reporting the laboratory methodology and definitions of clinical outcome and, c) "Clinical Guidance" (or "Positioning") - which should be used for official printouts that provide expert advice on challenges in patient management.</p>
    <p>It is imperative that the documents issued by SBC should be presented with adequate titration and background to avoid confusing the reader in the differentiation of terms and, consequently, disinterest in reading them. Therefore, the main objective of this publication is to establish in a simplified and objective way, the meaning of these terminologies, aiming to standardize the issuance of Guidelines, Communications and Guidances by SBC.</p>
    <sec>
      <title>Positioning document</title>
      <p>These documents aim to address a particular topic (diagnostic, therapeutic or laboratory) of recognized clinical interest, for which there are no (or unlikely to exist) evidence of substantial quality or, especially, those from randomized clinical trials. These documents are complementary to the guidelines and are prepared by a team of professionals with established experience in the subject.</p>
      <p>As an example, we could cite the use of direct anticoagulants in pregnant patients.<xref ref-type="bibr" rid="B5">5</xref> In general, the guidelines contained in these documents are anchored in the best evidence available; however, often incorporate the personal opinion of specialists.</p>
    </sec>
    <sec>
      <title>Clinical Guideline</title>
      <p>Clinical guideline consists of systematically developed assertions to assist health professionals and patients in making decisions about the most appropriate form of health care under specific conditions.<xref ref-type="bibr" rid="B6">6</xref> Unlike a guidance document, a guideline addresses a topic where there is evidence of moderate to high quality, usually from randomized trials with a satisfactory number of members, to convey the most appropriate clinical practices.</p>
      <p>In its elaboration, a process is used to summarize the evidences (that is, systematic review) and to provide a standardized method to express the degrees of recommendations with their respective levels of evidences. To produce a guideline, it is recommended that a rigorous checklist of 146 items be followed.<xref ref-type="bibr" rid="B2">2</xref>
			</p>
      <p>Therefore, these documents rarely address medical practice where evidence is scarce. They are designed to support decision-making processes in patient care; its content is based on a systematic review of clinical evidence.</p>
    </sec>
    <sec>
      <title>Normative document</title>
      <p>These devices differ from those listed above since they address topics primarily focused on the standardization of clinical, laboratory and research methodologies. As an example, we could cite the Subcommittee on Anticoagulation Control of the International Society of Thrombosis and Hemostasis to measure the anticoagulant activity of factor Xa inhibitors.<xref ref-type="bibr" rid="B7">7</xref> Therefore, it is a useful tool available to SBC departments.</p>
      <p>The movement toward evidence-based health care has been rising rapidly in recent years, motivated by clinicians, policymakers and managers concerned about the quality, consistency, and cost of health care.</p>
      <p>Thus, the above-mentioned documents, based on standardized best practices, provided they are written in a practical and objective manner, may be able to promote improvements in the quality and consistency of health care.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="supported-by">
        <p>
          <bold>Sources of Funding</bold>
        </p>
        <p>There were no external funding sources for this study.</p>
      </fn>
      <fn fn-type="other">
        <p>
          <bold>Study Association</bold>
        </p>
        <p>This study is not associated with any thesis or dissertation work</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1</label>
        <mixed-citation>1 Qaseem A, Forland F, Macbeth F, Ollenschl&#228;ger G, Phillips S, van der Wees P; Board of Trustees of the Guidelines International Network. Guidelines International Network: toward international standards for clinical practice guidelines. Ann Intern Med. 2012;156(7):525-31. doi: 10.7326/0003-4819-156-7-201204030-00009.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qaseem</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Forland</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Macbeth</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ollenschl&#228;ger</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>van der Wees</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Board of Trustees of the Guidelines International Network. Guidelines International Network: toward international standards for clinical practice guidelines</article-title>
          <source>Ann Intern Med</source>
          <year>2012</year>
          <volume>156</volume>
          <issue>7</issue>
          <fpage>525</fpage>
          <lpage>531</lpage>
          <pub-id pub-id-type="doi">10.7326/0003-4819-156-7-201204030-00009</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation>2 Schunemann HJ, Wiercioch W, Etxeandia I, Falavigna M, Santesso N, Mustafa R, et al. Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise. CMAJ. 2014;186(3):E123-42. doi: 10.1503/cmaj.131237.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schunemann</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Wiercioch</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Etxeandia</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Falavigna</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Santesso</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Mustafa</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise</article-title>
          <source>CMAJ</source>
          <year>2014</year>
          <volume>186</volume>
          <issue>3</issue>
          <fpage>E123</fpage>
          <lpage>E142</lpage>
          <pub-id pub-id-type="doi">10.1503/cmaj.131237</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation>3 Afiune Neto A, Zago AJ, Pereira Barreto AC, Guimar&#227;es AC, Brito AH, Brand&#227;o AP, et al; Sociedade Brasileira de Cardiologia. Relat&#243;rio da Sub-comiss&#227;o de T&#237;tulo de Especialista e Educa&#231;&#227;o M&#233;dica Continuada e Pol&#237;tica Cient&#237;fica dos Congressos. Arq Bras Cardiol.1992;59(4):1-8.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Afiune</surname>
              <given-names>A</given-names>
              <suffix>Neto</suffix>
            </name>
            <name>
              <surname>Zago</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Pereira Barreto</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Guimar&#227;es</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Brito</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Brand&#227;o</surname>
              <given-names>AP</given-names>
            </name>
            <etal/>
            <collab>Sociedade Brasileira de Cardiologia</collab>
          </person-group>
          <article-title>Relat&#243;rio da Sub-comiss&#227;o de T&#237;tulo de Especialista e Educa&#231;&#227;o M&#233;dica Continuada e Pol&#237;tica Cient&#237;fica dos Congressos</article-title>
          <source>Arq Bras Cardiol</source>
          <year>1992</year>
          <volume>59</volume>
          <issue>4</issue>
          <fpage>1</fpage>
          <lpage>8</lpage>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <mixed-citation>4 Douketis JD, Weitz JI. Guidance, guidelines, and communications. J Thromb Haemost. 2014;12(10):1744-5. doi: 10.1111/jth.12708.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Douketis</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Weitz</surname>
              <given-names>JI</given-names>
            </name>
          </person-group>
          <article-title>Guidance, guidelines, and communications</article-title>
          <source>J Thromb Haemost</source>
          <year>2014</year>
          <volume>12</volume>
          <issue>10</issue>
          <fpage>1744</fpage>
          <lpage>1745</lpage>
          <pub-id pub-id-type="doi">10.1111/jth.12708</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <mixed-citation>5 Ginsberg JS, Crowther MA. Direct oral anticoagulants (DOACs) and pregnancy: a plea for better information. Thromb Haemost. 2016;116(4):590-1. doi: 10.1160/TH16-08-0602.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ginsberg</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Crowther</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Direct oral anticoagulants (DOACs) and pregnancy: a plea for better information</article-title>
          <source>Thromb Haemost</source>
          <year>2016</year>
          <volume>116</volume>
          <issue>4</issue>
          <fpage>590</fpage>
          <lpage>591</lpage>
          <pub-id pub-id-type="doi">10.1160/TH16-08-0602</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <mixed-citation>6 Institute of Medicine (US) Committee to Advise the Public Health Service on Clinical Practice Guidelines ; Field MJ, Lohr KN, editors. Washington (DC): National Academies Press (US); 1990.</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Institute of Medicine (US) Committee to Advise the Public Health Service on Clinical Practice Guidelines</collab>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Field</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Lohr</surname>
              <given-names>KN</given-names>
            </name>
          </person-group>
          <publisher-loc>Washington (DC)</publisher-loc>
          <publisher-name>National Academies Press (US)</publisher-name>
          <year>1990</year>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <mixed-citation>7 Baglin T, Hillarp A, Tripodi A, Elalamy I, Buller H, Ageno W. Measuring oral direct inhibitors of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2013 Jan 24. [Epub ahead of print]. doi: 10.1111/jth.12149.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baglin</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hillarp</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tripodi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Elalamy</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Buller</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ageno</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Measuring oral direct inhibitors of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis</article-title>
          <source>J Thromb Haemost</source>
          <day>24</day>
          <month>01</month>
          <year>2013</year>
          <comment>[Epub ahead of print]</comment>
          <pub-id pub-id-type="doi">10.1111/jth.12149</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="s1" xml:lang="pt">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Ponto de vista</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Posicionamentos, Diretrizes e Normatiza&#231;&#245;es. Ve&#237;culos de Aux&#237;lio &#224; Pr&#225;tica M&#233;dica</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Sousa</surname>
            <given-names>Ant&#244;nio Carlos Sobral</given-names>
          </name>
          <xref ref-type="aff" rid="aff7">1</xref>
          <xref ref-type="aff" rid="aff8">2</xref>
          <xref ref-type="corresp" rid="c2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cunha</surname>
            <given-names>Claudio Pereira da</given-names>
          </name>
          <xref ref-type="aff" rid="aff9">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Magalh&#227;es</surname>
            <given-names>Luc&#233;lia Batista Neves Cunha</given-names>
          </name>
          <xref ref-type="aff" rid="aff10">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kaiser</surname>
            <given-names>Sergio Emanuel</given-names>
          </name>
          <xref ref-type="aff" rid="aff11">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Saraiva</surname>
            <given-names>Jos&#233; Francisco Kerr</given-names>
          </name>
          <xref ref-type="aff" rid="aff12">6</xref>
        </contrib>
      </contrib-group>
      <aff id="aff7">
        <label>1</label>
        <institution content-type="original">Departamento de Medicina e N&#250;cleo de P&#243;s gradua&#231;&#227;o em medicina da Universidade Federal de Sergipe, Aracaju, SE; - Brasil</institution>
      </aff>
      <aff id="aff8">
        <label>2</label>
        <institution content-type="original">Centro de Ensino e Pesquisa da Funda&#231;&#227;o S&#227;o Lucas, Aracaju, SE; - Brasil</institution>
      </aff>
      <aff id="aff9">
        <label>3</label>
        <institution content-type="original">Universidade Federal do Paran&#225;, Curitiba, PR; - Brasil</institution>
      </aff>
      <aff id="aff10">
        <label>4</label>
        <institution content-type="original">Universidade Federal da Bahia, Slavador, BA; - Brasil</institution>
      </aff>
      <aff id="aff11">
        <label>5</label>
        <institution content-type="original">Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ; - Brasil</institution>
      </aff>
      <aff id="aff12">
        <label>6</label>
        <institution content-type="original">Pontif&#237;cia Universidade Cat&#243;lica de Campinas (PUC-Camp), S&#227;o Paulo, SP; - Brasil</institution>
      </aff>
      <author-notes>
        <corresp id="c2"><bold>Correspond&#234;ncia: Ant&#244;nio Carlos Sobral Sousa</bold>, Av. Dep. Silvio Teixeira, 490/1201. CEP 49025-100, Jardins, Aracaju, SE - Brasil. E-mail: <email>acssousa@terra.com.br</email></corresp>
        <fn fn-type="con">
          <p>
            <bold>Contribui&#231;&#227;o dos autores</bold>
          </p>
          <p>Concep&#231;&#227;o e desenho da pesquisa, obten&#231;&#227;o de dados, an&#225;lise e interpreta&#231;&#227;o dos dados e an&#225;lise estat&#237;stica: Sousa ACS, Cunha CP, Magalh&#227;es LBNC, Kaiser SE, Saraiva JFK; Obten&#231;&#227;o de financiamento: Sousa ACS, Cunha CP; Reda&#231;&#227;o do manuscrito e Revis&#227;o cr&#237;tica do manuscrito quanto ao conte&#250;do intelectual importante: Sousa ACS.</p>
        </fn>
        <fn fn-type="conflict">
          <p>
            <bold>Potencial conflito de interesses</bold>
          </p>
          <p>Declaro n&#227;o haver conflito de interesses pertinentes</p>
        </fn>
      </author-notes>
      <kwd-group xml:lang="pt">
        <title>Palavras-chave</title>
        <kwd>Pr&#225;tica Cl&#237;nica Baseada em Evid&#234;ncias</kwd>
        <kwd>Assist&#234;ncia &#224; Sa&#250;de</kwd>
        <kwd>Guias de Pr&#225;tica M&#233;dica como Assunto</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>Em um campo t&#227;o complexo e com r&#225;pidas mudan&#231;as como a cardiologia, as Diretrizes de Pr&#225;tica Cl&#237;nica s&#227;o ferramentas importantes para a aplica&#231;&#227;o de uma medicina baseada em evid&#234;ncias no atendimento ao paciente. Devemos, por&#233;m, ressaltar que a ader&#234;ncia &#224;s mesmas varia muito, e que, alguns m&#233;dicos t&#234;m preocupa&#231;&#245;es acerca de que estes instrumentos caracterizem uma pr&#225;tica r&#237;gida ou simplificada da medicina. Portanto, a implementa&#231;&#227;o apropriada de diretrizes de aten&#231;&#227;o &#224; sa&#250;de &#233; de grande interesse para organiza&#231;&#245;es nacionais, sociedades profissionais, prestadores de cuidados &#224; sa&#250;de, respons&#225;veis pol&#237;ticos, para o campo jur&#237;dico voltado &#224; medicina, pacientes e o p&#250;blico em geral. Dada a import&#226;ncia do tema, v&#225;rias ferramentas t&#234;m sido desenvolvidas para avaliar a credibilidade das diretrizes existentes,<xref ref-type="bibr" rid="B1">1</xref> e orienta&#231;&#245;es t&#234;m sido elaboradas passo a passo para a concretiza&#231;&#227;o de um documento pr&#225;tico e confi&#225;vel.<xref ref-type="bibr" rid="B2">2</xref>
			</p>
      <p>A Sociedade Brasileira de Cardiologia (SBC) tem publicado, sistematicamente, desde 1992, diretrizes sobre os temas mais relevantes da especialidade.<xref ref-type="bibr" rid="B3">3</xref> Todavia, foi registrada falta de discernimento no tocante a tr&#234;s conceitos importantes<xref ref-type="bibr" rid="B4">4</xref> na inten&#231;&#227;o de realizar diretrizes por parte dos departamentos que comp&#245;em a SBC: a) &#8220;Diretriz&#8221; - termo que deve ser reservado para o documento que sumariza, formalmente, as evid&#234;ncias nas &#225;reas de diagn&#243;stico e terap&#234;utica de patologias; b) &#8220;Comunica&#231;&#227;o&#8221; (ou &#8220;Normatiza&#231;&#227;o&#8221;- deve ser empregado para os manuscritos que informam a metodologia laboratorial e as defini&#231;&#245;es de desfecho cl&#237;nico e, c) &#8220;Orienta&#231;&#227;o Cl&#237;nica&#8221; (ou &#8220;Posicionamento&#8221;) - que deve ser utilizado para impressos oficiais que fornecem aconselhamento especializado sobre desafios na condu&#231;&#227;o de pacientes.</p>
      <p>Torna-se imperativo que os documentos emitidos pela SBC se apresentem com titula&#231;&#227;o e fundamenta&#231;&#227;o adequadas para que seja evitada, por parte do leitor, confus&#227;o na diferencia&#231;&#227;o dos termos e, consequentemente, desinteresse na leitura dos mesmos.</p>
      <p>Portanto, o objetivo principal desta publica&#231;&#227;o &#233; o de estabelecer de forma simplificada e objetiva o significado destas terminologias, visando padronizar a emiss&#227;o de Posicionamentos, Diretrizes e Normatiza&#231;&#245;es por parte da SBC.</p>
      <sec>
        <title>Documento de posicionamento</title>
        <p>Estes documentos visam abordar um determinado t&#243;pico (diagn&#243;stico, terap&#234;utico ou laboratorial) de reconhecido interesse cl&#237;nico, para o qual n&#227;o existem (ou &#233; improv&#225;vel que venham a existir) evid&#234;ncias de qualidade substancial ou, notadamente aquelas surgidas de ensaios cl&#237;nicos randomizados. Tais documentos s&#227;o complementares &#224;s diretrizes e s&#227;o elaborados por uma equipe de profissionais com experi&#234;ncia estabelecida no tema.</p>
        <p>Como exemplo, poder&#237;amos citar o uso dos anticoagulantes diretos em pacientes gestantes.<xref ref-type="bibr" rid="B5">5</xref> Em geral, as orienta&#231;&#245;es contidas nestes documentos permanecem ancoradas nas melhores evid&#234;ncias dispon&#237;veis; todavia, incorporam, frequentemente, a opini&#227;o pessoal dos especialistas.</p>
      </sec>
      <sec>
        <title>Diretriz cl&#237;nica</title>
        <p>A diretriz cl&#237;nica est&#225; constitu&#237;da por afirma&#231;&#245;es sistematicamente desenvolvidas para auxiliar profissionais de sa&#250;de e pacientes na tomada de decis&#227;o sobre a forma mais adequada de cuidado com a sa&#250;de em condi&#231;&#245;es espec&#237;ficas.<xref ref-type="bibr" rid="B6">6</xref> Ao contr&#225;rio de um documento de orienta&#231;&#227;o, uma diretriz aborda um t&#243;pico em que h&#225; evid&#234;ncias de moderada a alta qualidade, geralmente provenientes de ensaios randomizados com um n&#250;mero satisfat&#243;rio de integrantes, para transmitir as pr&#225;ticas cl&#237;nicas mais adequadas.</p>
        <p>Na sua elabora&#231;&#227;o &#233; utilizado um processo para resumir as evid&#234;ncias (ou seja, revis&#227;o sistem&#225;tica) e fornecer um m&#233;todo padronizado para expressar os graus de recomenda&#231;&#245;es com os seus respectivos n&#237;veis de evid&#234;ncias. Para produzir uma diretriz, recomenda-se que seja cumprida uma lista rigorosa de verifica&#231;&#227;o, composta de 146 itens.<xref ref-type="bibr" rid="B2">2</xref>
				</p>
        <p>Portanto, estes documentos raramente abordam pr&#225;tica m&#233;dica onde as evid&#234;ncias s&#227;o escassas. Eles s&#227;o projetados para apoiar os processos de tomada de decis&#227;o na assist&#234;ncia ao paciente; o seu conte&#250;do &#233; baseado em uma revis&#227;o sistem&#225;tica da evid&#234;ncia cl&#237;nica.</p>
      </sec>
      <sec>
        <title>Documento de normatiza&#231;&#227;o</title>
        <p>Estes dispositivos diferem dos acima relacionados uma vez que abordam t&#243;picos primariamente direcionados para padroniza&#231;&#227;o de pr&#225;ticas cl&#237;nicas, laboratoriais e de metodologias de pesquisa. Como exemplo, poder&#237;amos citar a comunica&#231;&#227;o do Subcomit&#234; de Controle de Anticoagula&#231;&#227;o da Sociedade Internacional de Trombose e Hemostasia para medir a atividade anticoagulante dos inibidores do fator Xa.<xref ref-type="bibr" rid="B7">7</xref> Portanto, trata-se de ferramenta &#250;til &#224; disposi&#231;&#227;o dos departamentos da SBC.</p>
        <p>O movimento em dire&#231;&#227;o aos cuidados de sa&#250;de baseados em evid&#234;ncias vem ganhando terreno rapidamente nos &#250;ltimos anos, motivado por cl&#237;nicos, pol&#237;ticos e gestores preocupados com a qualidade, consist&#234;ncia e custos da assist&#234;ncia m&#233;dica.</p>
        <p>Assim, os documentos acima mencionados, baseados nas melhores pr&#225;ticas padronizadas, desde que redigidos de forma pr&#225;tica e objetiva, podem ser capazes de promover melhorias na qualidade e consist&#234;ncia dos cuidados com a sa&#250;de.</p>
      </sec>
    </body>
    <back>
      <fn-group>
        <fn fn-type="supported-by">
          <p>
            <bold>Fontes de financiamento</bold>
          </p>
          <p>O presente estudo n&#227;o teve fontes de financiamento externas</p>
        </fn>
        <fn fn-type="other">
          <p>
            <bold>Vincula&#231;&#227;o acad&#234;mica</bold>
          </p>
          <p>N&#227;o h&#225; vincula&#231;&#227;o deste estudo a programas de p&#243;s-gradua&#231;&#227;o</p>
        </fn>
      </fn-group>
    </back>
  </sub-article>
</article>
